---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-24-000005"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:11:52.282100+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iBio secures $1.07M term loan from Loeb Term Solutions at Prime+8.5%, collateralized by assets except IP

## Summary
- Loan principal $1,071,572; net proceeds ~$1,027,455 after $42,863 origination fee.
- Interest at Prime Rate +8.5%; monthly payments over 4-year amortization, balloon due at 2 years.
- Secured by substantially all assets except filed patent-related IP.
- Personal indemnity guarantees from executives Dr. Martin Brenner and Felipe Duran.
- Prepayment fees: 4% (first 12 months), 3% (second 12 months).

## SEC filing metadata
- accession: 0001420720-24-000005
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000005/0001420720-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000005/ibio-20240116x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-24-000005
- JSON: https://secwatch.observer/filing/0001420720-24-000005.json
- Plain text: https://secwatch.observer/filing/0001420720-24-000005.txt

## Key facts
- Debt Financings
  iBio, Inc. incurred term loan of $1,071,572 with Loeb Term Solutions LLC at Prime Rate, as quoted in the Wall Street Journal plus 8.5%.
  - Instrument: term loan
  - Principal: $1,071,572
  - Counterparty: Loeb Term Solutions LLC
  - Rate: Prime Rate, as quoted in the Wall Street Journal plus 8.5%
  - Event: incurrence
  source text: On January 16, 2024, iBio, Inc. (the “Company”), entered into a credit and security agreement (the “Credit and Security Agreement”) with Loeb Term Solutions LLC, an Illinois limited liability company (“Lender”), for a term loan or equipment line of credit loan (the “Loan”) pursuant to which the Company issued to Lender a term promissory note in the principal amount of $1,071,572 (the “Term Note”) bearing interest at the Prime Rate, as quoted in the Wall Street Journal plus 8.5% (the “Effective Rate”), for proceeds of $1,027,455.23 after payment of $42,862.88 to Lender as an origination fee, $1,172.89 for appraisal costs, and $75.00 for bank wire fees.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000005/0001420720-24-000005-index.htm
- Material Agreements
  iBio, Inc. entered into Credit and Security Agreement with Loeb Term Solutions LLC valued at $1,071,572 (effective 2024-01-16).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Loeb Term Solutions LLC
  - Value: $1,071,572
  - Effective: 2024-01-16
  source text: On January 16, 2024, iBio, Inc. (the “Company”), entered into a credit and security agreement (the “Credit and Security Agreement”) with Loeb Term Solutions LLC, an Illinois limited liability company (“Lender”), for a term loan or equipment line of credit loan (the “Loan”) pursuant to which the Company issued to Lender a term promissory note in the principal amount of $1,071,572
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000005/0001420720-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.